Analysts have been eager to weigh in on the Healthcare sector with new ratings on Universal Health (UHS) and Teladoc (TDOC).
Universal Health (UHS)
Credit Suisse analyst A.J. Rice maintained a Buy rating on Universal Health yesterday and set a price target of $150.00. The company’s shares closed last Tuesday at $106.00.
According to TipRanks.com, Rice is a 4-star analyst with an average return of 4.6% and a 55.3% success rate. Rice covers the Healthcare sector, focusing on stocks such as Genesis Healthcare, Acadia Healthcare, and Community Health.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Universal Health with a $131.80 average price target, which is a 27.5% upside from current levels. In a report issued on April 13, RBC Capital also maintained a Buy rating on the stock with a $145.00 price target.
See today’s analyst top recommended stocks >>
Teladoc (TDOC)
In a report released today, Jailendra Singh from Credit Suisse maintained a Hold rating on Teladoc, with a price target of $152.00. The company’s shares closed last Tuesday at $180.69, close to its 52-week high of $203.86.
According to TipRanks.com, Singh is a 2-star analyst with an average return of 0.7% and a 54.5% success rate. Singh covers the Services sector, focusing on stocks such as AmerisourceBergen, Cardinal Health, and Owens & Minor.
Currently, the analyst consensus on Teladoc is a Moderate Buy with an average price target of $147.30, which is a -24.7% downside from current levels. In a report issued on April 14, Barclays also maintained a Hold rating on the stock with a $140.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
